Cañeda, Renz M.

HRN: 25-67-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2026
OXACILLIN 500MG (VIAL)
06/01/2026
06/07/2026
IV
225mg
Q6H
Abscess, Left Submandibular Area
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines